Skip to main content

Brain Cancers

Online First
Temodar Receives FDA Approval for New and Updated Indications and Doses Through the Project Renewal Program
FDA Approvals, News & Updates, Head & Neck Cancers , Brain Cancers
Online First
On September 14, 2023, the FDA approved new and updated indications for temozolomide (Temodar; Merck) capsules and injection, an alkylating drug, including for the adjuvant treatment of adults with newly diagnosed anaplastic astrocytoma, and for the treatment of adults with refractory anaplastic astrocytoma. The previously approved indication for the treatment of adults with newly diagnosed glioblastoma, concomitant with radiotherapy, then as maintenance treatment, remains unchanged. Read More ›
Molecular Characteristics Increasingly Define Adult Gliomas
By William King
NCCN 2023 Conference Highlights, Head & Neck Cancers , Brain Cancers , National Comprehensive Cancer Network (NCCN)
May 2023, Vol 13, No 5
Molecular/genetic characterization has taken on greater importance in the classification of adult gliomas and in diagnostic and treatment decision-making. “These tumors are now grouped and predicated more on molecular features rather than histopathologic criteria,” said L. Burt Nabors, MD, in a presentation during the 2023 National Comprehensive Cancer Network Annual Conference. Read More ›